A few hours after leaving Mediobanca, Angelini Investment, famous for example for Tachipirina, Tantum Verde and Pampers diapers, also decides to leave Unicredit to rebalance your portfolio.
Emanuele Campagnoli, CEO of the group's subsidiary a, says so MF. Those in Mediobanca and Unicredit were small but significant shares. And now the already positive financial position of the Italian group is growing with 2 billion in revenues in 2022, leaving the door open to hypotheses of new acquisitions in other fields, probably other than financial ones. “We have decided to exit the banking sector for rebalance our portfolio” said Campagnoli. “In fact we also sold our historic stake in Unicredit” he says. Of Mediobanca Angelini had the 0,47 % and Unicredit 0,06%.
Angelini: here is his varied portfolio
Angelini Investments it is the group company that invests the cash in companies in various sectors. To that pharmaceuticals has steadily supported the sector mass consumption, which it manages in partnership with the Americans of Procter & Gamble, in addition to industrial technologies, venture capital and some wine cellars.
Among the listed companies, Angelini Investment has placed in the portfolio Prysmian (0,38%), Tamburi Investment Partners (10,6%), Digital Magics (0,94%) and Revo (9,1%). The portfolio of investments in, however, is larger unlisted companies, such as 2,35% of Banca del Fucino and 1,7% of Talent Garden. Or the shares in the club deals promoted by Tip banker Giovanni Tamburi. The last investment dates back to December with the entry into the capital of Rina, the Italian multinational founded in 2000 by the Italian Naval Registry, through the newco E-Tic Coinvest.
The group, plagued in recent years by lawsuits between family members, is currently checked by Thea Paola Angelini with 68% (the remaining 32% is divided equally between Francesco Angelini and Angelini Finanziaria).
Angelini: how will you use the cash register now?
In 2022 the threshold of was exceeded 2 billion in revenues at a consolidated level (2,057 to be precise) against 1,79 billion in 2021. The industrial margin is worth 254 million and the group churned out a net profit of 80 million euros. The main drivers of the business in 2022 were healthcare products such as the Amuchina and Tachipirina, which have seen a boom in sales throughout the pandemic, while brands Pampers, ensure constant growth.
With the sale of shares Mediobanca e Unicredit the financial position of the group is further enriched and it is clear that the hypotheses of use of the cash register for other acquisitions. At the end of 2022 the group had a net financial position positive of 630 million and boasted bank deposits of 458 million and liquidity in securities for another 442 million, investing the cash is almost an obligation. The net worth is close to 3 billion compared to only 600 million in bank debt.
The exit from Mediobanca
In the last few hours Angelini has also left his historic share at Mediobanca, after 23 years (it had joined in 2001): it sold its 4 million shares (0,47%), which were part of the Shareholders' Agreement, to the blocks. The share, through intermediaries, was taken over by Plt Holding, company owned by the Tortora family and active in the renewable energy sector. Plt itself thus entered into the consultation agreement, together with Valsabbia Investimenti, a steel group controlled by the Brunori, Cerqui and Oliva families, which with its 0,14% strengthens the weight of a sector already represented by Lucchini (holders of 0,55%) and by Fin.Fer of the Pittini family (with 0,41%). The overall participation combined in the Pact thus rose to 10,98% from the previous 10,84%.
